Indicated for: prevention of measles, mumps and rubella
Route of administration: injectable
Substance: live attenuated measles vaccine (vaccine)
ATC: J07BD01 (Antiinfectives for systemic use | Viral vaccines | Measles vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Do not use this medicine during pregnancy.
Avoid live vaccines during treatment if contraindicated.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The live attenuated measles vaccine is used to prevent measles, a highly contagious viral disease caused by the measles virus. The vaccine contains a weakened form of the virus, which stimulates the immune system to produce specific antibodies against it, providing long-term protection against infection.
The vaccine is administered subcutaneously, usually in two doses, with the first dose given at 12-15 months of age and the second between 4 and 6 years. It is recommended for children and adults who have not been previously vaccinated or have not had measles.
Common side effects include fever, rashes, pain, or swelling at the injection site. In rare cases, severe adverse reactions such as febrile seizures or allergic reactions may occur.
The live attenuated measles vaccine is an essential preventive measure for reducing the incidence of measles and its associated complications, such as encephalitis or viral pneumonia.